Lyvispah Granule
Product Images NDC 64896-077
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lyvispah (NDC 64896-077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Ifu Image 1 (Lyvispah Baclofen Oral Granules 2)
5mg Ifc (Lyvispah Baclofen Oral Granules 3)
LYVISPAH is an oral medication that comes in granule form, with each packet containing 5 mg of baclofen. This product is for oral administration and comes in a carton containing 90 individual packets. It is important to note that transfer of this drug to any person other than the patient for whom it was prescribed is prohibited by federal law. The granules are easy to consume and can be mixed with soft food, a small amount of liquid, or given via enteral feeding tubes. The package contains instructions on administering with food and maintaining freshness. The product should be kept within 15-30°C (59-86°F) and kept out of reach of children.*
10mg Ifc (Lyvispah Baclofen Oral Granules 4)
This is a medication called Baclofen, which is available in a granule form and is used for oral administration. Each carton contains 90 individual packets with 10mg of Baclofen. The packet has instructions on administration and caution against transfer to others. The product is prepared using certain techniques and should be used within two hours of preparation. This medication should be kept out of reach of unsupervised children. Additionally, the safety seal has to be intact for consumption, and the prescription instructions and patient counseling information have to be referred to before use. Distributed by Amneal Pharmaceuticals LLC.*
20mg Ifc (Lyvispah Baclofen Oral Granules 5)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.